Skip to main content

Advertisement

Log in

Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT)

  • Original Article
  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

Oral mucositis (OM) is a debilitating and serious side effect in patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT). Laser therapy is becoming a promising treatment option in these patients, avoiding the necessity of enteral/parenteral nutrition. The aim of this study was to evaluate the efficacy of laser therapy in patients affected by oral mucositis induced by chemotherapy and HSCT. Sixteen onco-hematological pediatric patients receiving chemotherapy and hematopoietic stem cell transplantation, affected by oral mucositis, were enrolled in this study. They were divided in two randomized groups: the laser group and the placebo-control group. Patients in the laser group were treated with HPLT (970 ± 15 nm, 3.2 W (50%), 35–6000 Hz, 240 s) for four consecutive days, once a day; and placebo group underwent sham treatment. The assessment of mucositis was recorded through WHO Oral Mucositis Grading Objective Scale, and pain was evaluated through Visual Analogue Scale (VAS). Patients were monitored and evaluated 3, 7, and 11 days after the first day of laser therapy. Once OM was diagnosed, the patients had mucositis grading assessments before laser or sham application at day 3, 7, and 11 after first application. All patients of laser group demonstrated improvement in pain sensation from day 3 after first application of laser (p < 0.05), ulcerations reduced their dimensions and erythema disappeared. The patients of placebo group had improvement from day 7. In laser group, all mucositis were fully resolved from day 7 (p < 0.05). Oral mucositis negatively impacts on nutritional intake, oral hygiene, and quality of life. Laser therapy appears to be a safe and innovative approach in the management of oral mucositis. In this preliminary study, HPLT encourages to consider laser therapy as a part of onco-hematological protocol, providing to decrease pain and duration of OM induced by CT and HSCT. Further researches will be needed, especially randomized, controlled clinical trials with a large number of enrolled patients and a long term of follow-up to confirm the efficacy of laser therapy in prevention and control of OM in onco-hematological pediatric patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Worthington H, Clarkson J, Furness S, McCabe M, Khalid T (2010) Mayer S. Interventions for treating oral mucositis for patients with cancer receiving treatment, Cochrane

    Google Scholar 

  2. Cheng KK, Lee V, Li CH et al (2012) Oral mucositis on pediatric and adolescent patients undergoing chemotherapy: the impact of symptoms on quality of life. Support Care Cancer 20:2335–2342

    Article  PubMed  Google Scholar 

  3. Abramoff MM, Lopes NN, Lopes LA, Dib LL, Guilherme A, Caran EM, Barreto AD, Lee ML, Petrilli AS (2008) Low-level laser therapy in the prevention and treatment of chemotherapy-induced oral mucositis in young patients. Photomed Laser Surg 26(4):393–400

    Article  CAS  PubMed  Google Scholar 

  4. Antunes HS, de Azevedo AM, da Silva Bouzas LF, Adão CA, Pinheiro CT, Mayhe R, Pinheiro LH, Azevedo R, D'Aiuto de Matos V, Rodrigues PC, Small IA, Zangaro RA, Ferreira CG (2007) Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial. Blood 109(5):2250–2255

    Article  CAS  PubMed  Google Scholar 

  5. Arbabi-Kalati F, Arbabi-Kalati F, Moridi T (2013) Evaluation of the effect of low level laser on prevention of chemotherapy-induced mucositis. Acta Med Iran 51(3):157–162

    CAS  PubMed  Google Scholar 

  6. Sonis ST (2004) A biological approach to mucositis. J Support Oncol 2:21–36

    PubMed  Google Scholar 

  7. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995–2025

    Article  PubMed  Google Scholar 

  8. Spivakovsky S (2015 Jun) Low level laser therapy may reduce risk of oral mucositis. Evid Based Dent 16(2):49

    Article  PubMed  Google Scholar 

  9. National Cancer Instutute (NCI), National Institute Health (NIH), Common Toxicity Criteria (CTC), Version 2.0, March 1998.

  10. Scardina GA, Pisano T, Messina P (2010) Oral mucositis review of literature. N Y State Dent J 76:34–38

    PubMed  Google Scholar 

  11. Otmani N, Alami R, Hessissen L et al (2011) Determinants of severe oral mucositis in paediatric cancer patients: a prospective study. Int J Paediatr Dent 21:210–216

    Article  PubMed  Google Scholar 

  12. Lopez M, Gebbia N, Cascinu S et al. Oncologia medica Pratica. 3° Edizione, Società Editrice Universo, parte XIII, chapter.117,3196–3201.

  13. Qutob AF, Gue S, Revesz T, Logan RM, Keefe D (2013) Prevention of oral mucositis in children receiving cancer therapy: a systematic review and evidence-based analysis. Oral Oncol 49(2):102–107

    Article  PubMed  Google Scholar 

  14. Gobbo M, Ottaviani G, Bussani R et al (2013) Methotrexate-induced oral mucositis in rheumatoid arthritis disease: therapeutic strategy in a case report photonics. Laser Med 2:71–76

    CAS  Google Scholar 

  15. Gobbo M, Ottaviani G, Mustacchi G et al (2012) Acneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach. Laser Med Sci 27:1085–1090

    Article  CAS  Google Scholar 

  16. Miller MM, Donald DV, Hagemann TM (2012) Prevention and treatment of oral mucositis in children with cancer. J Pediatric Pharmacol Ther 17:340–350

    Google Scholar 

  17. Eduardo FP, Bezinelli L, Luiz AC, Correa L, Vogel C, Eduardo CP (2009) Severity of oral mucositis in patients undergoing hematopoietic cell transplantation and an oral laser phototherapy protocol: a survey of 30 patients. Photomed Laser Surg 27(1):137–144

    Article  PubMed  Google Scholar 

  18. Ottaviani G, Gobbo M, Sturnega M et al (2013) Effect of class IV laser therapy on chemotherapy-induced oral mucositis: a clinical and experimental study. Am J Pathol 183(6):1747–1757

    Article  PubMed  Google Scholar 

  19. Chermetz M, Gobbo M, Ronfani L, Ottaviani G et al (2014) Class IV laser therapy as treatment for chemotherapy-induced oral mucositis in onco-haematological paediatric patients: a prospective study. Int J Paediatr Dent 24(6):441–449

    Article  PubMed  Google Scholar 

  20. Treister NS, London WB, Guo D, Malsch M, Verrill K, Brewer J, Margossian S, Duncan C (2016) A feasibility study evaluating extraoral photobiomodulation therapy for prevention of mucositis in pediatric hematopoietic cell transplantation. Photomed Laser Surg 34(4):178–184

    Article  PubMed  Google Scholar 

  21. Soto M, Lalla RV, Gouveia RV, Zecchin VG, Seber A, Lopes NN (2015) Pilot study on the efficacy of combined intraoral and extraoral low-level laser therapy for prevention of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation. Photomed Laser Surg 33(11):540–546

    Article  PubMed  Google Scholar 

  22. Eduardo Fde P, Bezinelli LM, de Carvalho DL, Lopes RM, Fernandes JF, Brumatti M, Vince CS, de Azambuja AM, Vogel C, Hamerschlak N, Correa L (2015) Oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation: clinical outcomes in a context of specialized oral care using low-level laser therapy. Pediatr Transplant 19(3):316–325

    Article  PubMed  Google Scholar 

  23. Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Sonis ST, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DM, Genot MT, Lansaat L, van der Brink R, Arnabat-Dominguez J, van der Molen L, Jacobi I, van Diessen J, de Lange J, Smeele LE, Schubert MM, Bensadoun RJ (2016) Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Support Care Cancer 24(6):2781–2792

    Article  PubMed  PubMed Central  Google Scholar 

  24. Villa A, Sonis ST (2015) Mucositis: pathobiology and management. Curr Opin Oncol 27(3):159–164

    Article  CAS  PubMed  Google Scholar 

  25. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S (2014) Mucositis guidelines leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120(10):1453–1461

    Article  PubMed  PubMed Central  Google Scholar 

  26. Passarella S, Karu T (2014) Absorption of monochromatic and narrow band radiation in the visible and near IR by both mitochondrial and non-mitochondrial photoreceptors results in pho-bio-modulation. J Photochem Photobiol B 140:344–358

    Article  CAS  PubMed  Google Scholar 

  27. Medeiros Filho JB, Maia Filho EM, Ferreira MC (2017) Laser and photochemotherapy for the treatment of oral mucositis in young patients: randomized clinical trial. Photodiagnosis Photodyn Ther 18:39–45

    Article  PubMed  Google Scholar 

  28. Kuhn A, Porto FA, Miraglia P, Brunetto AL (2009) A low-level infrared laser therapy in chemotherapy-induced oral mucositis: a randomized placebo-controlled trial in children. J Pediatr Hematol Oncol 31(1):33–37

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marina Consuelo Vitale.

Ethics declarations

Ethical Committee approved the protocol.

Experiments were undertaken with the understanding and written consent of each subject and in full accordance with ethical principles.

Conflict of interests

The authors declare that there is no conflict of interests and no financial support with any organization regarding the material discussed in the manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vitale, M.C., Modaffari, C., Decembrino, N. et al. Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT). Lasers Med Sci 32, 1423–1428 (2017). https://doi.org/10.1007/s10103-017-2266-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10103-017-2266-y

Keywords

Navigation